Anna Reid

1.2k total citations
34 papers, 919 citations indexed

About

Anna Reid is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Anna Reid has authored 34 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Anna Reid's work include Cancer Immunotherapy and Biomarkers (13 papers), Cancer Cells and Metastasis (11 papers) and Cancer Genomics and Diagnostics (11 papers). Anna Reid is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Cancer Cells and Metastasis (11 papers) and Cancer Genomics and Diagnostics (11 papers). Anna Reid collaborates with scholars based in Australia, United States and United Kingdom. Anna Reid's co-authors include Mel Ziman, Elin S. Gray, Michael Millward, James Freeman, Muhammad A. Khattak, Tarek Meniawy, Michelle R. Pereira, Kelvin Shenq Woei Siew, Johnny Lo and Markus H. Frank and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and European Heart Journal.

In The Last Decade

Anna Reid

33 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Reid Australia 15 508 449 363 192 150 34 919
Nora Berois Uruguay 17 195 0.4× 106 0.2× 543 1.5× 282 1.5× 67 0.4× 33 865
Shira Gal Israel 15 144 0.3× 1.4k 3.0× 1.3k 3.7× 124 0.6× 97 0.6× 24 2.0k
Hassan Rahimi Italy 20 282 0.6× 61 0.1× 374 1.0× 442 2.3× 88 0.6× 51 856
Rüdiger Rüger Germany 16 240 0.5× 265 0.6× 498 1.4× 96 0.5× 60 0.4× 24 836
Sarah L. Lake United Kingdom 16 270 0.5× 74 0.2× 250 0.7× 159 0.8× 109 0.7× 20 712
Xiufen Lei United States 14 740 1.5× 303 0.7× 519 1.4× 171 0.9× 41 0.3× 27 1.2k
Zhenqing Feng China 14 368 0.7× 150 0.3× 261 0.7× 204 1.1× 59 0.4× 26 674
Rurika Oka Netherlands 15 233 0.5× 221 0.5× 800 2.2× 82 0.4× 66 0.4× 23 1.3k
Oliver Elliott United States 6 165 0.3× 404 0.9× 532 1.5× 164 0.9× 75 0.5× 8 1.0k

Countries citing papers authored by Anna Reid

Since Specialization
Citations

This map shows the geographic impact of Anna Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Reid more than expected).

Fields of papers citing papers by Anna Reid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Reid. The network helps show where Anna Reid may publish in the future.

Co-authorship network of co-authors of Anna Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Reid. A scholar is included among the top collaborators of Anna Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Reid. Anna Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Osborne, Douglas G., Dinoop Ravindran Menon, Derek Smith, et al.. (2023). CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients. Frontiers in Immunology. 14. 1173035–1173035. 10 indexed citations
3.
Beasley, Aaron B., Leslie Calapre, Timothy Isaacs, et al.. (2023). Detection of metastases using circulating tumour DNA in uveal melanoma. Journal of Cancer Research and Clinical Oncology. 149(16). 14953–14963. 8 indexed citations
4.
Calapre, Leslie, Tindaro Giardina, Aaron B. Beasley, et al.. (2023). Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies. Scientific Reports. 13(1). 278–278. 14 indexed citations
5.
Beasley, Aaron B., Timothy Isaacs, Tersia Vermeulen, et al.. (2021). Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture. Cancers. 13(23). 5990–5990. 9 indexed citations
6.
McEvoy, Ashleigh C., Michelle R. Pereira, Anna Reid, et al.. (2021). Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression. British Journal of Cancer. 126(3). 401–408. 23 indexed citations
7.
Warburton, Lydia, Leslie Calapre, Michelle R. Pereira, et al.. (2020). Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression. Cancers. 12(11). 3486–3486. 11 indexed citations
8.
Khattak, Muhammad A., Anna Reid, Ashleigh C. McEvoy, et al.. (2020). Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study. Frontiers in Oncology. 10. 1041–1041. 12 indexed citations
9.
Johansson, Peter A., Michelle R. Pereira, Ashleigh C. McEvoy, et al.. (2020). The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies—Beyond BRAF Mutant Detection. Cancers. 12(12). 3793–3793. 16 indexed citations
10.
McEvoy, Ashleigh C., Michelle R. Pereira, Anna Reid, et al.. (2019). Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies. Oncotarget. 10(2). 113–122. 21 indexed citations
11.
Dunkel, Ying, Anna Reid, Jason Ear, et al.. (2018). Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma. Scientific Reports. 8(1). 18036–18036. 6 indexed citations
12.
Khattak, Muhammad A., Elin S. Gray, Anna Reid, et al.. (2018). PD-L1 expression on pre-treatment circulating tumour cells, but not serum VEGF, is predictive of response to pembrolizumab in melanoma. Annals of Oncology. 29. viii24–viii25. 2 indexed citations
13.
Gray, Elin S., Anna Reid, Samantha Bowyer, et al.. (2015). Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology. 135(8). 2040–2048. 64 indexed citations
14.
15.
Reid, Anna, James Freeman, Michael Millward, Mel Ziman, & Elin S. Gray. (2014). Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clinical Biochemistry. 48(15). 999–1002. 84 indexed citations
16.
Gray, Elin S., James Freeman, Anna Reid, et al.. (2014). Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer. 14(1). 423–423. 45 indexed citations
17.
Reid, Anna, et al.. (2009). Identification of novel and zoonotic Cryptosporidium species in marine fish. Veterinary Parasitology. 168(3-4). 190–195. 42 indexed citations
18.
Yang, Rongchang, Anna Reid, Alan J. Lymbery, & Una Ryan. (2009). Identification of zoonotic Giardia genotypes in fish. International Journal for Parasitology. 40(7). 779–785. 32 indexed citations
19.
Reid, Anna, et al.. (2008). Use of azithromycin in cystic fibrosis patients not infected with Pseudomonas aeruginosa. Journal of Cystic Fibrosis. 7. S25–S25. 3 indexed citations
20.
Reid, Anna. (2000). Australian cuttlefishes (Cephalopoda : Sepiidae): the 'doratosepion' species complex. Invertebrate taxonomy. 14(1). 1–76. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nora Berois Breakdown of academic impact, for papers by Shira Gal Breakdown of academic impact, for papers by Hassan Rahimi Breakdown of academic impact, for papers by Rüdiger Rüger Breakdown of academic impact, for papers by Sarah L. Lake Breakdown of academic impact, for papers by Xiufen Lei Breakdown of academic impact, for papers by Zhenqing Feng Breakdown of academic impact, for papers by Rurika Oka Breakdown of academic impact, for papers by Oliver Elliott
Rankless by CCL
2026